Kerim Babaoglu
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)United States Military Academy(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Computational Drug Discovery Methods, Biochemical and Molecular Research, HIV/AIDS drug development and treatment, Metabolism and Genetic Disorders
Most-Cited Works
- → Validation of Molecular Docking Programs for Virtual Screening against Dihydropteroate Synthase(2009)614 cited
- → A High-Throughput Screen for Aggregation-Based Inhibition in a Large Compound Library(2007)355 cited
- → Structural basis for selectivity and diversity in angiotensin II receptors(2017)212 cited
- → Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)(2016)178 cited
- → Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase(2008)178 cited
- → Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis(2003)176 cited